ArticleCase reports in critical care2026
Safety of Early Mobilisation in Critically Ill Patients Under Unusual High-Risk Conditions: A Latin American Case Series.
Article in Case reports in critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Safety of Early Mobilisation in Critically Ill Patients Under Unusual High-Risk Conditions: A Latin American Case Series.Case reports in critical care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early mobilisation (EM) in the intensive care unit (ICU) is associated with a reduced incidence of intensive care unit-acquired weakness, shorter hospital length of stay and improved functional outcomes. However, most of the available evidence derives from patient populations at low risk of safety-related adverse events. This limits the generalisability of its benefits to more complex clinical scenarios, such as the concurrent administration of blood products, continuous parenteral nutrition, antiarrhythmic infusions or multiple haemodynamic pharmacological support. Consequently, evidence regarding the safety of EM in these contexts remains scarce. This case series is aimed at describing the safety of EM under unusual and high-risk clinical conditions, an area that remains underexplored in the international literature. Case Presentation: We describe six critically ill patients presenting with conditions traditionally considered high risk for EM. Two patients were receiving active transfusion of blood products: a 70-year-old woman under invasive mechanical ventilation and a 69-year-old man with upper gastrointestinal bleeding and moderate anaemia; both performed active exercises during red blood cell transfusion. Two additional patients were receiving continuous enteral nutrition: a 42-year-old man requiring invasive mechanical ventilation and a 76-year-old woman; both undertook active exercises during nutritional administration. The fifth case involved a 65-year-old woman with atrial flutter treated with an amiodarone infusion. The sixth case was a 65-year-old woman with cardiomyopathy and suspected sepsis, requiring triple haemodynamic pharmacological support with noradrenaline, vasopressin and dobutamine. Exercise prescription was individualised according to intensity, type and duration, based on the dosing determined by the attending physiotherapist. All interventions were conducted under continuous monitoring. No adverse events or complications related to EM or invasive devices were observed. Conclusions: EM can be safely implemented in critically ill patients, even under conditions traditionally considered high risk, provided that strict criteria for clinical stability and continuous monitoring are applied. These findings provide relevant preliminary evidence supporting the feasibility of active rehabilitation in the ICU and open new avenues for research aimed at defining specific safety criteria for EM in high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.